Interventions that normalize/reduce plasma insulin concentrations might play a key role in the prevention and treatment of age-related decline, obesity, type 2 diabetes, cardiovascular disease and cancer. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.